Skip to main content Skip to content

Predicting Ketamine Response in Depression: Biomarkers and Early Changes

Scroll to read
Back to Resources & Blog

Written by The Care Clinic Team. Published by Resova Infusions and TMS. Medically reviewed by Dr. Siddharth Arora, DO, MS.

Predicting Ketamine Response in Depression: Biomarkers and Early Changes

When Ketamine Infusion Might Change the Trajectory of Depression

Ketamine infusion has opened a real door for people whose depression has not shifted with standard medications. After years of treating complex mood disorders, we have seen ketamine help many patients experience relief when other treatments failed. For some, the change can come within days instead of weeks, which can matter a lot when life is already demanding and you are expected to keep up. That can feel especially sharp in the summer, when people around you may look relaxed and happy while you are still struggling to get out of bed. Ketamine works very differently from traditional antidepressants. Instead of primarily affecting serotonin or norepinephrine, ketamine acts on the glutamate system and can rapidly enhance neuroplasticity, your brain’s ability to form new connections. That mechanism helps explain why, for some individuals, the change can feel profound, especially in treatment-resistant depression. But the response is not uniform, and benefits can fade over time without a thoughtful maintenance plan. In our work with complex mood disorders, we see a wide range of outcomes. Many patients have meaningful relief, some feel a profound shift, and others notice little change even with a careful course of ketamine. The big question we ask with each person is: based on who you are, your body, your brain, and how you respond to early sessions, how likely is ketamine infusion to actually help your depression?

What Predicting Ketamine Response Really Means

When we talk about predicting response, we are talking about probabilities, not certainties. Two people with long histories of treatment-resistant depression can sit in the same chair, receive the same dose, and walk away with very different results. It helps to be clear about a few terms we use every day in our Fairfax psychiatry and infusion practice:
  • Treatment-resistant depression: usually means you have tried several antidepressants at solid doses and for long enough, without good relief  
  • Response: noticeable improvement in symptoms, but not full relief  
  • Remission: symptoms are minimal or gone, and daily life feels workable again  
  • Acute response: what happens in the hours to weeks after ketamine infusions  
  • Sustained benefit: how much of that improvement holds up over months  
For us, “success” is not just a mood score. We care about whether you can get to work more reliably, connect with others, keep yourself safe, and feel less trapped in your own mind. Prediction matters because it helps us set realistic expectations before starting, limit exposure to treatments that may not be worth the effort or side effects, and decide between ketamine infusion, TMS, medication changes, or a combined plan.

Biomarkers Under Study: Brain, Blood, and Beyond

Researchers are working hard to find better ways to predict who will respond to ketamine. Some of the most discussed ideas are “biomarkers,” clues in the brain or body that might give us a hint. Areas under study include:
  • Brain activity patterns on EEG  
  • Functional MRI findings that show how brain regions talk to each other  
  • Inflammatory markers in the blood, like C-reactive protein (CRP)  
  • Levels of brain-derived neurotrophic factor (BDNF), which is linked to neuroplasticity  
  • Measures related to glutamate, the main signaling system ketamine affects  
Early data suggest that certain patterns of brain connectivity, certain levels of inflammation, or certain neurotrophic markers might relate to better or poorer response. The problem is that no one has a perfect threshold or single number that says “this will work” or “this will not.” At Resova Infusions and TMS, we stay current with biomarker research, and it shapes how we think about the science. But in real-world daily practice, we do not base treatment plans on one blood test or scan. A careful psychiatric evaluation, medical review, and real-time observation still matter far more than any single lab value.

Clinical Clues and Early-Session Changes

In day-to-day psychiatry, clinical patterns often tell us more than lab tests. People who may be more likely to benefit from ketamine infusion often share features like:
  • Clear history of major depressive episodes  
  • Multiple failed antidepressant or augmentation trials  
  • Deep anhedonia, where almost nothing feels rewarding  
  • Significant loss of function at work, school, or home over time  
Other factors can shape response without ruling ketamine out:
  • Coexisting anxiety, PTSD, or bipolar spectrum features  
  • Longstanding personality traits that affect relationships or coping  
  • Substance use history, including alcohol or stimulants  
  • Chronic pain conditions and other medical problems  
These elements call for thoughtful planning, not automatic exclusion. We weigh your past treatment responses, current symptoms, and safety profile to decide whether to recommend ketamine infusion first, TMS first, a combination of both or a sequence of both, or a different strategy entirely. Once treatment starts, the first one to three ketamine infusions give us more information than any prediction model. During these early sessions, we pay close attention to:
  • Shifts in overall mood “load,” even if small  
  • Reduction in suicidal thoughts or intensity of hopelessness  
  • Changes in energy, motivation, or ability to start tasks  
  • Sleep quality and patterns  
  • A sense of being “less stuck” or more flexible in thinking  
Some people feel lighter within hours to a day. Others change more slowly across a full series. Some have strong dissociation during the infusion but little mood change afterward. That split matters, because transient dissociation alone is not the goal. We want to see life between sessions start to move. Based on early trends, we may adjust dose or infusion timing, integrate psychotherapy when neuroplasticity is likely higher, consider adding or transitioning to TMS, or decide to stop if there is no meaningful signal of benefit after an adequate trial.

Integrating Ketamine, TMS, and Ongoing Care Over Time

We see ketamine infusion and TMS as tools in a larger plan, not last resorts. For long-standing, seasonal, or recurrent depression, it is rare that a single treatment solves everything forever. Ketamine’s benefits are often time-limited. Some patients experience a clear lift that gradually fades over weeks to months. Because of that, we plan from the beginning for how to sustain gains, which may include:
  • Booster ketamine infusions spaced out over time, when clinically appropriate  
  • Ongoing psychotherapy to make use of new flexibility in thinking  
  • Medication adjustments once mood has lifted enough to tolerate change  
  • A later TMS course to build more stable improvement  
TMS (transcranial magnetic stimulation) is an FDA-cleared treatment for major depressive disorder, especially when standard medications have not provided adequate relief. It is non-systemic, non-sedating, and for some patients offers durable benefit after a full course. At the same time, TMS requires a significant time commitment, typically near-daily sessions over several weeks, and it is not effective for everyone. “One and done” is almost never the right expectation for ketamine, TMS, or any other single intervention. Instead, we focus on steady monitoring with:
  • Mood and anxiety ratings  
  • Side effect tracking  
  • Questions about work, relationships, and daily self-care  
  • Regular review of diagnosis as your brain and symptoms shift with treatment  

How Careful Screening and Oversight Protect Your Progress

Good outcomes start with careful screening. At Resova Infusions and TMS, our evaluation usually includes:
  • A detailed psychiatric interview and review of past treatment trials  
  • Medical history and current medications  
  • Lab work when appropriate, based on your health and safety needs  
  • Substance use and safety assessment, including risk of self-harm  
It is also important to be explicit about the regulatory status of different approaches. IV ketamine infusions for depression are considered an off-label use of ketamine, meaning the medication is FDA-approved for other indications but not specifically for treatment-resistant depression. We use it based on growing evidence and clinical experience, while being clear that this is not an officially approved indication. During ketamine infusion, we keep clear safety boundaries, such as:
  • Cardiovascular and respiratory monitoring  
  • Review of potential medication interactions  
  • Clear guidance about driving and important decisions on treatment days  
  • Protocols to respond to blood pressure changes, nausea, anxiety, or non-response  
After years of working with ketamine and TMS, we are confident in their potential, but we stay humble about prediction. No clinician can promise a certain outcome. We focus instead on shared decision-making, honest feedback about how things are going, and a willingness to rethink the plan if ketamine or TMS is not giving the level of benefit we hoped for. If you feel stuck after multiple medications, it is reasonable to explore options like ketamine infusion and TMS with informed confidence. Take time to reflect on your own history, including how different seasons affect you, what you have already tried, and what “meaningful improvement” would actually look like in your daily life. At Resova Infusions and TMS in Fairfax, we have seen these treatments be transformative for the right patients, and a careful, individualized evaluation is the first step in finding out whether they fit your situation.

Take The First Step Toward Lasting Relief Today

If you are ready to explore a different approach to managing your symptoms, we are here to walk you through each step. At Resova Infusions and TMS, our experienced team will help you determine whether a tailored ketamine infusion plan is right for you. Reach out to schedule a consultation so we can review your history, answer your questions, and outline your next best steps. Let us partner with you to move toward relief, stability, and a better quality of life.

Clinical context and sources

TMS devices have FDA clearance for specific indications. Eligibility, risks and likely benefits depend on the device, protocol and condition being treated. NIMH: Brain Stimulation Therapies.

IV ketamine for depression is an off-label treatment. It is distinct from FDA-approved intranasal esketamine; a clinician must assess suitability and monitoring needs. NIMH: Cracking the Ketamine Code (2023).

These references provide context for the topics discussed. They do not establish that a particular treatment is appropriate for every reader or guarantee an individual outcome.

A calming clinical backdrop for the contact section

Request an appointment

Start your journey to relief today.

Most patients are seen within 24 hours of their initial consultation. We accept major insurance including Aetna, Blue Cross Blue Shield, Cigna, United Healthcare, and Tricare. TMS and Spravato may be covered for qualifying conditions, depending on your insurance and plan; not every plan covers them, and both require prior authorization. Insurance does not cover ketamine infusions, but it may cover your office visit. Complete the form or call us directly – our team will verify your benefits and schedule your first appointment.

Our board-certified team specializes in ketamine infusion therapy, TMS (Transcranial Magnetic Stimulation), and Spravato treatment for depression, anxiety, PTSD, OCD, and chronic pain. We serve patients throughout Northern Virginia from our Fairfax clinic, including McLean, Vienna, Reston, Arlington, Falls Church, and the greater DC metro area.

During your consultation, Dr. Arora will review your medical history, current symptoms, and previous treatments to determine if interventional psychiatry is right for you. We believe in personalized care – no two treatment plans are exactly alike because no two patients are exactly alike.

Call the clinic
Call us 571-418-8141 ext. 6
Email us infusions@resovahealth.com
Connect with us

Ivy

Book an appointment
Verify your phone to book your own appointment. This form is not monitored for crises. For an emergency, call 911; for a mental health crisis, call or text 988.
Please enter your phone number to authenticate: